Pierre Fabre Castres - Peraudel — Company Profile

Institut de Recherche Pierre Fabre 17, Avenue Jean Moulin 81106 Castres Cedex France Tel.: +33 (0)5 63 71 42 00 Fax: +33 (0)5 63 35 66 29 Website: http://www.pierre-fabre.com/

Medical chemistry (central nervous system, cardio-vascular diseases).

Sector of activity
Research & Development

Branch of activity
Pharmacy

Personnel
232 Persons


Source: Pierre Fabre

[Read more!]

Pierre Fabre Ramonville - Ariane — Company Profile

Institut de Recherche Pierre Fabre Parc Technologique du Canal 3, rue Ariane 31527 Ramonville Cedex France Tel.: +33 (0)5 61 73 73 00 Fax: +33 (0)5 61 73 73 73 Website: http://www.pierre-fabre.com/

Innovation Development Center Pierre Fabre.

Sector of activity
Research & Development

Branch of activity
Pharmacy

Personnel
142 Persons


Source: Pierre Fabre

[Read more!]

Pierre Fabre Labège I — Company Profile

Centre de Développement Pierre Fabre (CDPF) Rue Jean Rostand BP 687 31319 Labège-Innopole Cedex France Tel.: +33 (0)5 62 24 27 00 Fax: +33 (0)5 61 39 96 50 Website: http://www.pierre-fabre.com/

Invent a new galenic, ensure the development of new actives, validate pre-clinical and clinical drug dossiers.

Brands
Pierre Fabre Medicament

Sector of activity
Research & Development

Branch of activity
Pharmacy


Source: Pierre Fabre

[Read more!]

Pierre Fabre Gaillac — Company Profile

Plantes & Industrie ZA des Clergous 16, rue Jean Rostand 81603 Gaillac Cedex France Tel.: +33 (0)5 63 81 24 00 Fax: +33 (0)5 63 57 32 07 Website: http://www.pierre-fabre.com/ Website: http://www.plantes-industrie.com/

Plant extracts, pure actives, neutraceutics. Actives produced through hemisynthesis or total synthesis. FDA approval.

Brands
Pierre Fabre Medicament

Sector of activity
Research & Development

Branch of activity
Pharmacy

Personnel
329 persons


Source: Pierre Fabre

[Read more!]

Pierre FABRE donates the majority equity interest in his company to his Foundation and appoints Jean-Pierre GARNIER general manager of Pierre FABRE SA

Castres, 29 August 2008 — Faithful to the commitment made in 2005 to his employees, Mr. Pierre FABRE asked the Pierre Fabre Foundation’s board of directors to accept the donation of 100% of the equity of Pierre Fabre Participation, a holding company with a 60% share in Laboratoires Pierre Fabre. The aim of this operation is to secure the long-term independence of Pierre Fabre SA, a company founded in 1961 in Castres with a turnover of €1.7 billion in pharmaceuticals, family medical products and dermocosmetics.

At the same time, Mr. Pierre FABRE expressed his intention to transform Pierre Fabre SA into a company under a Supervisory Committee, chaired by him, with Mr. GARNIER heading the management board.

Mr. Jean-Pierre GARNIER, 60, was CEO of the world’s second biggest pharmaceuticals group, GlaxoSmithKline Beecham, until last May. An Officer of the Legion of Honour, Mr. GARNIER has been a member of the French Healthcare Industries Strategic Council since the organisation was founded.

When announcing this decision, Mr. Pierre FABRE stated: "we are fortunate to have a man with so much experience in the global pharmaceutics arena in the person of Jean-Pierre GARNIER, who will enable us to successfully sustain the considerable R&D efforts the company has been making over the past few years and amplify its growth."


About Pierre Fabre SA

Pierre Fabre SA achieved a turnover of €1.7 billion in 2007 and employs a workforce of nearly 10,000. It ranks as the second biggest independent laboratory in France and leads the in-pharmacy cosmetics sector, which accounts for half the group’s turnover.

The Pierre Fabre Foundation is a registered charity founded by order of the prime minister on 8 April 1999. It is chaired by Mr. Pierre Fabre and works to promote good pharmaceutical practice and improve healthcare in developing countries.


Source: Company

[Read more!]